Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ALNYLAM-PHARMACEUTICALS-I-8322/news/Roche-and-Alnylam-present-positive-results-from-the-Phase-II-KARDIA-2-study-of-zilebesiran-added-to-46386264/?utm_source=whatsapp&utm_medium=social&utm_campaign=share